Stephens restated their equal weight rating on shares of ModivCare (NASDAQ:MODV – Free Report) in a research note issued to investors on Friday,Benzinga reports. Stephens currently has a $17.00 target price on the stock, down from their prior target price of $21.00.
A number of other research firms have also recently commented on MODV. Barrington Research restated an “outperform” rating and set a $25.00 target price on shares of ModivCare in a research report on Monday, November 18th. Jefferies Financial Group cut their price objective on ModivCare from $25.00 to $14.00 and set a “hold” rating for the company in a research report on Friday, September 13th. Finally, Lake Street Capital decreased their target price on ModivCare from $50.00 to $30.00 and set a “buy” rating on the stock in a research report on Tuesday, September 17th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $25.20.
Check Out Our Latest Stock Analysis on MODV
ModivCare Trading Down 47.5 %
ModivCare (NASDAQ:MODV – Get Free Report) last posted its earnings results on Wednesday, November 6th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.49 by ($0.04). The firm had revenue of $702.04 million during the quarter, compared to analyst estimates of $711.28 million. ModivCare had a negative net margin of 6.57% and a positive return on equity of 26.14%. The business’s revenue for the quarter was up 2.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.35 earnings per share. As a group, analysts forecast that ModivCare will post 0.64 EPS for the current year.
Insider Transactions at ModivCare
In other ModivCare news, major shareholder Q Global Capital Management, L purchased 20,556 shares of the stock in a transaction that occurred on Friday, October 25th. The shares were purchased at an average cost of $14.65 per share, for a total transaction of $301,145.40. Following the completion of the transaction, the insider now owns 1,520,394 shares of the company’s stock, valued at $22,273,772.10. The trade was a 1.37 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders have bought 307,242 shares of company stock valued at $4,894,217 over the last ninety days. Insiders own 22.10% of the company’s stock.
Institutional Trading of ModivCare
A number of hedge funds have recently bought and sold shares of MODV. HG Vora Capital Management LLC purchased a new stake in shares of ModivCare in the third quarter valued at approximately $17,136,000. Millennium Management LLC grew its holdings in ModivCare by 83.2% in the 2nd quarter. Millennium Management LLC now owns 841,295 shares of the company’s stock valued at $22,076,000 after buying an additional 381,995 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC increased its stake in shares of ModivCare by 0.8% in the 2nd quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 683,665 shares of the company’s stock worth $17,939,000 after acquiring an additional 5,644 shares during the last quarter. State Street Corp raised its holdings in shares of ModivCare by 1.5% during the 3rd quarter. State Street Corp now owns 349,750 shares of the company’s stock worth $4,994,000 after acquiring an additional 5,115 shares during the period. Finally, Renaissance Technologies LLC boosted its position in shares of ModivCare by 11.7% during the 2nd quarter. Renaissance Technologies LLC now owns 304,299 shares of the company’s stock valued at $7,985,000 after acquiring an additional 31,800 shares during the last quarter.
ModivCare Company Profile
ModivCare Inc, a technology-enabled healthcare services company, provides a suite of integrated supportive care solutions for public and private payors and their members. The company operates through four segments: Non-Emergency Medical Transportation (NEMT), Personal Care, Remote Patient Monitoring (RPM), and Corporate and Other.
See Also
- Five stocks we like better than ModivCare
- What is the FTSE 100 index?
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- What to Know About Investing in Penny Stocks
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for ModivCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ModivCare and related companies with MarketBeat.com's FREE daily email newsletter.